Apr 14, 2022 7:30 am EDT MindMed Collaborator Dr. Matthias Liechti to Present Topline Clinical Trial Results for LSD in Anxiety Disorders at PSYCH Symposium
Mar 21, 2022 7:30 am EDT MindMed to Host Earnings Call to Discuss Full-Year 2021 Financial Results and Provide Business Update
Mar 2, 2022 7:30 am EST MindMed Announces Publication of Study Comparing the Acute Effects of Lysergic Acid Diethylamide and Psilocybin in Healthy Subjects
Jan 25, 2022 7:30 am EST FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder